NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 7 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd.
August 06, 2023
Share
On August 7, 2023, NEXTURNBIOSCIENCE Co., Ltd. closed the transaction. The company received KRW 7,000,000,000 in the transaction.
Flask Co Ltd, formerly Gemvaxzio Co Ltd, is a Korea-based company engaged in the interior business. The Company operates its business through three segments. The Interior Business segment is involved in the businesses of interior design and construction, such as furniture design, manufacture and installation, as well as architectural design and construction. The Energy Business segment mainly engages in the construction of renewable energy devices and facilities, such as ice thermal storage cooling systems and electricity storage systems (ESSs). The Leasing Business segment mainly engages in the leasing of shops.
NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 7 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd.
FLASK CO., LTD. 
